维普期刊资源整合服务平台（V6.5）

58篇 您的检索式：作者名="Kovarik JM"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Cyclosporine pharmacokinetic and variability from a microemulsion formulation: a multicenter investigation in ki dney transplant patients显示文摘	Kovarik JM Mueller EA van-Bree JB	1994	Transplantation1994，58，6：	1
2	Everolimus in pulmonary transplantation: pharmacokinetics and exposure-response relationships显示文摘	Kovarik JM Snell GI Valentine V	2006	J Heart Lung Transplant2006，25，4：	1
3	Influence ofhepatic impairment on everolimus pharmacokinetics : implicationsfor dose adjustment 显示文摘	KOVARIK JM SABIA HD FIGUEIREDO J	2001	Clin Pharmacol Ther2001，70，5：	1
4	Kverolimus druginteractions: application of a classification system for clinical de-cision making显示文摘	KOVARIK JM BEYER D SCHMOLDEK RL	2006	Biopharm Drug Dispos2006，27，9：	1
5	Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites显示文摘	Kovarik JM Mueller EA Zehender H	1995	Antimicrob Agents Chemother1995，39，12：	1
6	Everolimus drug interactions: application of a classification system for clinical decision making显示文摘	Kovarik JM Beyer D Schmouder RL	2006	Biopharm Drug Dispos2006，27，9：	1
7	Blood concentrations of everolimus are markedly increased by ketoconazole显示文摘	Kovarik JM Beyer D Bizot MN	2005	J Clin Pharmacol2005，45，5：	1
8	Differential influence of two ey- elosporine formulations on everolimus pharmaeokineties: a clinically rele- vant pharmaeokinetic drug interaction 显示文摘	Kovarik JM Kalbag J Figueiredo J	2002	J Clin Pharmacol2002，42，1：	1
9	Pharmacokinetic interaction be- tween verapamil and everolimus in healthy subjects显示文摘	Kovarik JM Beyer D Bizot MN	2005	Br J Clin Phar- macol2005，60，4：	1
10	Multiple-dose FTY720: tolerability, pharmacokinetics, and lymphocyte responses in healthy subjects 显示文摘	Schmouder R Barilla D	2004	J Clin Pharmacol2004，44，5：	1
11	Ketoconazole increases fingolimod blood levels in a drug interaction via CYP4F2 inhibition显示文摘	Kovarik JM Dole K Riviere GJ		0，，02：	1
12	Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients-a concentration-controlled comparison with the commercial formulation显示文摘	Mueller EA Kovarik JM van Bree JB	1994	Transplantation1994，57，8：	1
13	Reduced inter-and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation显示文摘	Kovarik JM Mueller EA van Bree JB	1994	Pharm Sci1994，83，3：	1
14	Everolimus drug interactions: appli- cation of a classification system for clinical deeision making 显示文摘	Kovarik JM Beyer D Schmouder RL	2006	Biopharm Drug Dispos2006，27，9：	1
15	Cyclosporine pharmacokinetics and variability from a microemulsion formulation-a multicenter investigation in kidney transplant patients显示文摘	Kovarik JM Mueller EA van Bree JB	1994	Transplantation1994，58，6：	1
16	Pharmacokinetic and pharmaco- dynamic assessments of HMG - CoAreductase inhibitors when coadmini- stered with everolimus显示文摘	Kovarik JM Hartmann S Hubert S	2002	See comment in PubMed Commons below J Clin Pharmacol2002，42，2：	1
17	Population pharmacokinetics of everolimus in de novo renal transplant patients: impact of ethnicity and comedications 显示文摘	Kovarik JM Hsu CH McMahon L	2001	Clin Pharmacol Ther2001，70，3：	1
18	Variability in pharmacokinetic values for gentamicin tobramycin and netimicin in patients with renal insufficiency显示文摘	Matzke GR Millikin SP Kovarik JM	1989	Clin Pharm1989，8，：	1
19	Overview of FTY720 clinical pharmacokinetics and pharmacology显示文摘	Kovarik JM Schmouder RL Slade AJ	2004	Ther Drug Monit2004，26，6：	1
20	Sandimmune Neoral pharmacokinetics:impact of the new oral formulation显示文摘	Holt DW Mueller EA Kovarik JM	1995	Transpl Proc1995，27，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示